• SENSEX 76,515.43
    362.57 (+0.48%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
  • Gland Pharma
    2,969.85 3,039.00(%)
  • Power Fin.Corpn.
    357.70 486.45(%)
  • IFCI
    107.45 107.45(%)
  • Shriram Finance
    1,036.40 584.25(%)
  • Tata Technolog.
    796.45 507.50(%)
  • ESDS Software
    895.55 895.55(%)
  • Lenskart Solut.
    694.75 694.75(%)
  • Netweb Technol.
    5,170.00 2,514.75(%)
  • Lumino Inds
    122.00 122.00(%)
  • Kesar India
    1,180.00 1,341.00(%)
  • Multi Comm. Exc.
    3,287.00 3,479.80(%)
  • Tejas Networks
    623.90 644.75(%)
  • RBL Bank
    417.00 417.00(%)
  • ICICI AMC
    2,960.00 2,528.90(%)
  • Polycab India
    8,254.00 6,660.50(%)
  • New India Assura
    234.60 234.60(%)
  • Wockhardt
    2,107.95 2,420.00(%)
  • Angel One
    308.20 360.20(%)
  • Jindal Worldwide
    57.06 57.06(%)
  • Lalithaa Jewel
    308.55 308.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lincoln Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 12683.0
  • ISIN : INE405C01035
620.80 -2 (-0.30%)
  • As on 06 Sep 2026 (EOD)

  • Today’s Low

    618.00

  • Today’s High

    631.00

  • Open

    627.00

  • Perv Close

    622.65

  • 52W Low

    440.00

  • 52W High

    770.00

Key Indicators

  • P/E(TTM)

    12.85

  • Mar.Cap (₹Cr.)

    1,243.45

  • Div & Yield %

    0.29

  • Book Value(₹)

    378.25

  • Debt-Equity Ratio

    -0.30

  • AGM Date

    04-Sep-2026

  • EPS

    48.15

  • P/E Ratio

    12.85

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    1,243.45

  • RONW (%)

    17.04

  • ROCE (%)

    22.35

Score Board

  • Equity (₹ in Cr.)

    20.03

  • BV (₹)

    378.30

  • Sales( ₹ in Cr.)

    671.03

  • NP (in Cr.)

    87.89

  • NP Var(%)

    8.0

  • Div%

    18.0

  • CPS (₹)

    51.10

  • EPS (₹)

    43.90

  • Traded Value (₹ in Lakhs)

    1,239.34

  • 52 Week High

    770.00

  • 52 Week Low

    440.00

  • Price BSE

    619.0

  • Price NSE

    621.00

  • Market Capital( in Cr.)

    1,239.34

  • P/C Ratio

    12.10

  • P/E Ratio

    14.10

  • Price Vs.BV

    43.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 623.23 580.55 510.31 472.08 422.91 376.09
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 623.23 580.55 510.31 472.08 422.91 376.09
Other Income 22.48 34.42 22.48 10.00 5.74 12.13
Stock Adjustments -8.84 5.70 4.24 13.57 -3.67 5.86
Total Income 636.87 620.67 537.03 495.65 424.98 394.08
EXPENDITURE :            
Raw Materials 282.48 284.04 245.64 232.15 193.26 192.63
Power and Fuel Cost 11.66 11.47 10.25 8.33 7.10 7.57
Employee Cost 112.45 102.90 93.16 79.72 63.20 54.90
Other Manufacturing Expenses 27.93 23.70 19.55 16.61 16.27 14.35
Selling and Administration Expenses 75.28 60.99 54.50 50.88 50.80 49.58
Miscellaneous Expenses 3.10 3.24 2.28 2.50 1.58 3.54
Employee Benefit Expenses 112.45 102.90 93.16 79.72 63.20 54.90
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 512.90 486.34 425.39 390.18 332.20 322.57
Operating Profit 123.97 134.33 111.65 105.47 92.78 71.50
Interest 1.88 1.46 2.03 1.45 1.55 1.98
Gross Profit 122.09 132.87 109.62 104.02 91.23 69.52
Depreciation 12.90 10.62 9.17 8.09 7.56 5.47
Profit Before Tax 109.19 122.25 100.45 95.93 83.67 64.05
Current Tax 25.33 25.44 25.97 25.85 21.17 14.72
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.52 3.49 1.59 0.72 0.25 -0.24
Reported Net Profit 82.35 93.30 72.90 69.35 62.25 49.56
Extraordinary Items 1.31 1.07 0.37 0.61 -0.09 -0.03
Adjusted Net Profit 81.04 92.23 72.53 68.74 62.34 49.59
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -0.62
P & L Balance brought forward 507.46 417.66 348.26 282.41 220.66 170.09
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.11 3.50 3.50 3.50 0.50 7.12
P & L Balance carried down 585.70 507.46 417.66 348.26 282.41 211.92
Dividend 0.00 0.00 0.00 0.00 0.00 3.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 18.00 18.00 15.00 15.00 15.00 15.00
Dividend Per Share(Rs) 1.80 1.80 1.50 1.50 1.50 1.50
Earnings Per Share-Unit Curr 41.11 46.58 36.40 34.63 31.08 24.78
Earnings Per Share(Adj)-Unit Curr 41.11 46.58 36.40 34.63 31.08 24.78
Book Value 335.34 295.98 250.86 216.12 182.92 152.25
Book Value(Adj)-Unit Curr 335.34 295.98 250.86 216.12 182.92 152.25

Shareholding Pattern

  • Promoter Group

    49.78%

  • Public Share Holding

    50.22%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,081,000 5.40 1,081,000 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,888,930 44.38 8,888,930 22
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,969,930 49.78 9,969,930 25
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 921,028 4.60 921,028 45
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 395 0.00 395 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 53,568 0.27 53,568 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 974,991 4.87 974,991 49
2] Non Institution
Bodies Corporate 197,333 0.99 197,333 128
Clearing Members 19,622 0.10 19,622 19
Directors of their Relatives 478,400 2.39 478,400 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 494,305 2.47 494,305 642
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 573,713 2.86 573,713 620
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,356,243 11.76 2,356,243 40
Individuals holding nominal share capital up to Rs. 1 lakh 4,877,965 24.35 4,788,441 27,852
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 59,684 0.30 59,684 3
Sub Total 9,084,807 45.36 8,995,283 29,322
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 20,029,728 100.00 19,940,204 29,396

Company Background

Lincoln Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Lincoln Pharmaceuticals Ltd
  • BSE Code : 12683.0
  • ISIN : INE405C01035

  • Incorporation Year

    1995

  • Registered Office

    Lincoln House B/H Satyam Compe
    Science City Road Sola, Ahmedabad,
    Gujarat-380060

  • Telephone

    91-079-67778000

  • FAX

    91-079-67778062

  • Chairman

    Kishorbhai M Shah

  • Managing Director

  • Company Secretary

    Trusha Shah

  • Auditor

    Samir M Shah & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Lincoln Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lincoln Pharma. 618.75 645.71 623.23 12.85 17.42
Abbott India 26,071.95 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,930.80 2,304.07 2,275.58 102.15 27.86
Glaxosmi. Pharma 2,958.60 3,932.76 3,790.20 47.26 58.17
Novartis India 1,637.10 393.10 354.33 41.34 15.94
Cipla 1,385.00 20,102.60 18,979.95 36.40 13.88
Bliss GVS Pharma 668.70 773.53 729.81 62.09 12.51
Amrutanjan Healt 506.25 520.13 502.55 27.12 24.16
Fermenta Biotec. 498.35 474.15 450.25 23.27 18.77
Guj. Themis Bio. 411.75 152.47 150.80 110.09 27.21
Ambalal Sarabhai 43.72 19.52 3.94 80.96 6.77